Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure, featuring a Boc-protected primary amine and a free secondary methylamino group on a hexyl chain, allows for selective modification of amine functionalities, making it valuable in medicinal chemistry for protecting group strategies during multi-step syntheses. Commonly employed in the preparation of peptide analogs and targeted therapies where controlled amine reactivity is required. Also utilized in the creation of specialty polymers and functional materials due to its stability and selective deprotection characteristics under mild acidic conditions, such as with TFA.